British Society for Antimicrobial Chemotherapy
2011Detecting carbapenemases in non fermentersDetecting carbapenemases in EnterobacteriaceaeQuestions & Answers
2010Methods of detecting reduced susceptibility to glycopeptides in S.aureusAutomated systems: an overviewOur experiences with PhoenixVancomycin Susceptibility Testing in S.aureusVitek 2 - a user experienceEUCAST - Harmonising antimicrobial susceptibility testing in EuropeQuestions & Answers2009ESBL DetectionQuestions & Answers
2007Shift to European (EUCAST) breakpoints - the impact on the BSAC recommendationsSusceptibility testing of mucoid Pseudomanas and Burkholderia strains from patients with cystic fibrosis including evaluation of the BSAC Standardized MethodsBSAC recommendations for interpreting the susceptibility of urinary tract isolatesSusceptibility testing new agents eg. linezolid, tigecycline, daptomycin and dalbavancinDetection of ESBLs and AmpC beta-lactamase2006BSAC Disc Diffusion MethodConfirmation tests for the detection of AmpCSusceptibility testing anaerobesGeneral questions and answers about BSAC methodologyClinical data to support the inerpretation of susceptibility testing of anaerobes
2005Expert rules and inexpensive identificattion methodsCefoxitlin for the detection of methicillin/oxacillian resistance in staphylococciAntibacterial drug developmentMost often asked questionsExpert rules and inexpensive identification methods
2004Recent Changes to the RecommendationsVeterinary Susceptibility TestingDetection of beta-lactamase-mediated resistanceAntimicrobial susceptibility testing in Europe - the role of national breakpoint committees and EUCASTDoes suceptibility testing have a role in predicting clinical or microbiological outcome?
2003Determination of the antimicrobial susceptibility of Neisseria gonorrhoeaeSurveillance of ResistanceBSAC rolling programme for devising acceptable limits for control strainsDetection of beta-lactamase-mediated resistanceQuality Assurance of Antimicrobial Susceptibility Testing
